Structural and functional characterization of interactions between the dihydropyridine receptor II-III loop and the ryanodine receptor

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 11, 2006, Pages 1114-1117

  Casarotto, Marco G ^a   Cui, Yanfang ^a   Karunasekara, Yamuna ^a   Harvey, Peta J ^a   Norris, Nicole ^a   Board, Philip G ^a   Dulhunty, Angela F ^a  

^a Biology and Environment   (Australia)

Author keywords

Dihydropyridine receptor; Excitation contraction coupling; II III loop; Nuclear magnetic resonance; Protein protein interaction; Ryanodine receptor

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; RYANODINE RECEPTOR;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CALCIUM TRANSPORT; CONFERENCE PAPER; EXCITATION CONTRACTION COUPLING; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE;

BINDING SITES; CALCIUM CHANNELS, L-TYPE; PROTEIN BINDING; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 33750087518     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04501.x     Document Type: Conference Paper

References (29)

1. Dulhunty AF, Haarmann CS, Green D, Laver DR, Board PG, Casarotto MG. Interactions between dihydropyridine receptors and ryanodine receptors in striated muscle. Prog. Biophys. Mol. Biol. 2002; 79: 45-75.
2. 2+ channels. Biochem. J. 2006; 394: 145-52.
3. Casarotto MG, Green D, Pace S, Young J, Dulhunty AF. Activating the ryanodine receptor with dihydropyridine receptor II-III loop segments: Size and charge do matter. Front. Biosci. 2004; 9: 2860-72.
4. Lu X, Xu L, Meissner G. Activation of the skeletal muscle calcium release channel by a cytoplasmic loop of the dihydropyridine receptor. J. Biol. Chem. 1994; 269: 6511-16.
5. Samso M, Wagenknecht T. Contributions of electron microscopy and single-particle techniques to the determination of the ryanodine receptor three-dimensional structure. J. Struct. Biol. 1998; 121: 172-80.
6. Samso M, Shen X, Allen PD. Structural characterization of the RyR1-FKBP12 interaction. J. Mol. Biol. 2006; 356: 917-27.
7. el-Hayek R, Antoniu B, Wang J, Hamilton SL, Ikemoto N. Identification of calcium release-triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 1995; 270: 22 116-18.
8. Proenza C, Wilkens CM, Beam KG. Excitation-contraction coupling is not affected by scrambled sequence in residues 681-690 of the dihydropyridine receptor II-III loop. J. Biol. Chem. 2000; 275: 29 935-7.
9. 1S II-III loop. Proc. Natl Acad. Sci. USA 2001; 98: 5892-7.
10. 1s pore subunit. Biophys. J. 2001; 81: 3294-307.
11. Gurrola GB, Arevalo C, Sreekumar R, Lokuta AJ, Walker JW, Valdivia HH. Activation of ryanodine receptors by imperatoxin A and a peptide segment of the II-III loop of the dihydropyridine receptor. J. Biol. Chem. 1999; 274: 7879-86.
12. Casarotto MG, Gibson F, Pace SM, Curtis SM, Mulcair M, Dulhunty AF. A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop. J. Biol. Chem. 2000; 275: 11 631-7.
13. Casarotto MG, Green D, Pace SM, Curtis SM, Dulhunty AF. Structural determinants for activation or inhibition of ryanodine receptors by basic residues in the dihydropyridine receptor II-III loop. Biophys. J. 2001; 80: 2715-26.
14. Green D, Pace S, Curtis SM et al. The three-dimensional structural surface of two β-sheet scorpion toxins mimics that of an α-helical dihydropyridine receptor segment. Biochem. J. 2003; 370: 517-27.
15. Dulhunty AF, Curtis SM, Watson S, Cengia L, Casarotto MG. Multiple actions of imperatoxin A on ryanodine receptors: Interactions with the II-III loop 'A' fragment. J. Biol. Chem. 2004; 279: 11 853-62.
16. Haarmann CS, Green D, Casarotto MG, Laver DR, Dulhunty AF. The random-coil 'C' fragment of the dihydropyridine receptor II-III loop can activate or inhibit native skeletal ryanodine receptors. Biochem. J. 2003; 372: 305-16.
17. 2+ inhibition. Biochem. J. 2005; 387: 429-36.
18. Tanabe T, Beam KG, Powell JA, Numa S. Restoration of excitation- contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature 1988; 336: 134-9.
19. 1S II-III loop for skeletal-type excitation-contraction coupling. J. Biol. Chem. 2004; 279: 4721-8.
20. Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. Relat. Areas Mol. Biol. 1978; 47: 45-148.
21. Dulhunty AF, Karunasekara Y, Curtis SM, Harvey PJ, Board PG, Casarotto MG. Role of some unconserved residues in the 'C' region of the skeletal DHPR II-III loop. Front. Biosci. 2005; 10: 1368-81.
22. Dulhunty AF, Karunasekara Y, Curtis SM, Harvey PJ, Board PG, Casarotto MG. The recombinant dihydropyridine receptor II-III loop and partly structured 'C' region peptides modify cardiac ryanodine receptor activity. Biochem. J. 2005; 385: 803-13.
23. Catanzariti AM, Soboleva TA, Jans DA, Board PG, Baker RT. An efficient system for high-level expression and easy purification of authentic recombinant proteins. Protein Sci. 2004; 13: 1331-9.
24. 15N assignments for the II-III loop region of the skeletal dyhydropyridine receptor. J. Biomol. NMR 2005; 32: 89-90.
25. Gillespie JR, Shortle D. Characterization of long-range structure in the denatured state of staphylococcal nuclease. I. Paramagnetic relaxation enhancement by nitroxide spin labels. J. Mol. Biol. 1997; 268: 158-69.
26. Tjandra N, Bax A. Direct measurement of distances and angles in biomolecules by NMR in a dilute liquid crystalline medium. Science 1997; 278: 1111-14.
27. Leong P, MacLennan DH. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 1998; 273: 7791-4.
28. 2+-release channels). Trends Biochem. Sci. 1997; 22: 193-4.
29. Liu Z, Zhang J, Wang R, Wayne Chen SR, Wagenknecht T. Location of divergent region 2 on the three-dimensional structure of cardiac muscle ryanodine receptor/calcium release channel. J. Mol. Biol. 2004; 338: 533-45.